Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Rowe

Showing results (371-380 of 504) with videos related to

Pageof 51
Sort By:
Annals of Nuclear Medicine|December 8, 2017
Use of quantitative SPECT/CT reconstruction in <sup>99m</sup>Tc-sestamibi imaging of patients with renal massesKrystyna M Jones, Lilja B Solnes, Steven P Rowe, et al.
Urology|April 8, 2018
A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography ImagingRudolf A Werner, Christian Andree, Mehrbod S Javadi, et al.
Annals of Nuclear Medicine|June 1, 2019
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted <sup>18</sup>F-DCFPyL PET/CTAlexa R Meyer, Michael A Carducci, Samuel R Denmeade, et al.
Molecular Imaging and Biology|November 9, 2018
Impact of Tumor Burden on Quantitative [<sup>68</sup>Ga] DOTATOC BiodistributionRudolf A Werner, Heribert Hänscheid, Jeffrey P Leal, et al.
Quantitative Imaging in Medicine and Surgery|August 11, 2025
Comparison of standardized uptake value and standardized uptake lean body mass metrics in <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for assessing transformation in chronic lymphocytic leukemia and follicular lymphomaJorge D Oldan, Christopher E Jensen, Deborah M Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 TherapeuticsAkhilesh Mishra, Dhiraj Kumar, Kuldeep Gupta, et al.
The Prostate|May 5, 2025
Impact of Concomitant Hormone Therapy on the Diagnostic Performance of <sup>18</sup>F-Piflufolastat PET/CT in Prostate Cancer Patients: A Sub-Group Analysis of OSPREY Cohort BLawrence Saperstein, Steven P Rowe, Michael A Gorin, et al.
Theranostics|April 26, 2021
Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizonYoshitaka Toyama, Rudolf A Werner, Camilo A Ruiz-Bedoya, et al.
Hypertension (Dallas, Tex. : 1979)|August 8, 2025
Redefining AT1 Receptor PET Imaging: Introducing the Radiotracer [<sup>18</sup>F]DR29Xinyu Chen, Hiroyuki Kimura, Takanori Sasaki, et al.
Clinical Nuclear Medicine|July 25, 2017
Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade GliomasRoberto Andres Salas Fragomeni, Joshua R Menke, Matthias Holdhoff, et al.
Pageof 51

Showing results (371-380 of 504) with videos related to

Sort By:
Pageof 51
Annals of Nuclear Medicine|December 8, 2017
Use of quantitative SPECT/CT reconstruction in <sup>99m</sup>Tc-sestamibi imaging of patients with renal massesKrystyna M Jones, Lilja B Solnes, Steven P Rowe, et al.
Urology|April 8, 2018
A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography ImagingRudolf A Werner, Christian Andree, Mehrbod S Javadi, et al.
Annals of Nuclear Medicine|June 1, 2019
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted <sup>18</sup>F-DCFPyL PET/CTAlexa R Meyer, Michael A Carducci, Samuel R Denmeade, et al.
Molecular Imaging and Biology|November 9, 2018
Impact of Tumor Burden on Quantitative [<sup>68</sup>Ga] DOTATOC BiodistributionRudolf A Werner, Heribert Hänscheid, Jeffrey P Leal, et al.
Quantitative Imaging in Medicine and Surgery|August 11, 2025
Comparison of standardized uptake value and standardized uptake lean body mass metrics in <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for assessing transformation in chronic lymphocytic leukemia and follicular lymphomaJorge D Oldan, Christopher E Jensen, Deborah M Stephens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 TherapeuticsAkhilesh Mishra, Dhiraj Kumar, Kuldeep Gupta, et al.
The Prostate|May 5, 2025
Impact of Concomitant Hormone Therapy on the Diagnostic Performance of <sup>18</sup>F-Piflufolastat PET/CT in Prostate Cancer Patients: A Sub-Group Analysis of OSPREY Cohort BLawrence Saperstein, Steven P Rowe, Michael A Gorin, et al.
Theranostics|April 26, 2021
Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizonYoshitaka Toyama, Rudolf A Werner, Camilo A Ruiz-Bedoya, et al.
Hypertension (Dallas, Tex. : 1979)|August 8, 2025
Redefining AT1 Receptor PET Imaging: Introducing the Radiotracer [<sup>18</sup>F]DR29Xinyu Chen, Hiroyuki Kimura, Takanori Sasaki, et al.
Clinical Nuclear Medicine|July 25, 2017
Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade GliomasRoberto Andres Salas Fragomeni, Joshua R Menke, Matthias Holdhoff, et al.
Pageof 51